Explore therapeutic choices for patients with treatment-resistant depression, including ketamine, psilocybin, and various ...
SurvivorNet on MSN
Enhertu significantly cuts recurrence rates for women with high-risk HER2-positive breast cancer — the practice-changing DESTINY-Breast05 trial
For women with a specific type of breast cancer known as HER2-positive (HER2+), any residual (leftover) disease after primary ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback